Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Observational Non-Interventional Study With Enbrel in Patients With Ankylosing Spondylitis

This observational study will be a documentation of the prescribing and administration practices of Enbrel® and their impact on ankylosing spondylitis patients outcome in a real life setting.

The study population will be described using standard descriptive statistics for demographic, clinical, medical, characteristics, as well as for standard health-related quality of life and functional disability questionnaires .

Inclusion Criteria:

• Proven diagnosis of Ankylosing Spondylitisin accordance with local guidelines
• Patients treated as an outpatient

Exclusion Criteria:

• Patients who suffer from hypersensitivity to the active substance Etanercept or to any of the excipients of Enbrel®.
• Treatment with Enbrel® should not be initiated in patients with active infections including chronic or localised infections.
• Patients with sepsis or risk of sepsis should not be treated.